**About the Editors**

**Klaus Holzmann** (Prof. Dr.) is a senior scientist at the Comprehensive Cancer Center of the Medical University Vienna, with extensive experience in basic and translational cancer research, including techniques in molecular and cellular biology, to study fibroblast growth factor signaling and immortality for targeting and marker development. He is an active member of the American Association for Cancer Research (AACR), and has 75 publications in peer-reviewed journals and book chapters, and more than 1400 SCI citations, with an h-score of 24. He has coordinated, and participated in, national funded projects, and was previously a panel evaluator for the European Research Executive Agency (REA).

**Brigitte Marian** (Prof. Dr.) is a senior scientist at the Institute of Cancer Research at the Medical University of Vienna. She has long-standing experience in basic and translational cancer research as a principle investigator of peer-reviewed projects. The focus of her work is the investigation of tumor-specific signaling pathways aimed at marker and drug development. She has published more than 100 papers, with 1700 citations, and an h-index of 31.

*Editorial*
